Skip to content
Search

Latest Stories

Pharmacy bodies look forward to working with Steve Barclay again

Leading pharmacy bodies and associations are looking forward to working with 'reappointed' Secretary of State for Health and Social Care, Steve Barclay, on ‘future roles’ and ‘funding’ for the community pharmacy.

The Royal Pharmaceutical Society (RPS) England Country Board Chair, Thorrun Govind, hopes that the ministers will now be able to focus on addressing the key challenges facing the health service and the country.


“This means not just getting through the winter, but planning for and investing in the future.”

She added: “It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost of long-term conditions, and deliver best value from medicines.

Govind urged the minister "to support a more ambitious approach to advancing the clinical role of pharmacists across the NHS, including through a ‘Pharmacy First’ approach in England.”

“Amid warnings of potential cuts to public spending, I hope the Government listens to health and care leaders who are united in the need for a comprehensive workforce plan to deliver better patient care. This must include investment in pharmacy education and training.”

“As scientists and researchers, as well as clinicians, pharmacists also play a key role in pharmaceutical industry and will be vital to building on the UK’s position as a world leader in new therapies and technologies.”

On the reappointment of Steve Barclay to his former post of Secretary of State  for Health and Social Care, Dr Leyla Hannbeck, Chief Executive, Association of Independent Multiple Pharmacies (AIMp) said: “It is hoped the return of his brief will recognise the growing calls for community pharmacy in primary care and the wider NHS.”

“The network, it’s trust, respect and convenience for patients give the Secretary of State  a resounding platform to enhance our role by meeting many of the ambitions of the long term plan. We welcome the opportunities which now lay ahead to demonstrate how community pharmacy can play an integrated role in patient focused healthcare and population health.“

The National Pharmacy Association (NPA) looks forward to working constructively with Steve Barclay and his team, “aiming to secure the kind of support that will enable its members to help get the NHS back on its feet.”

NPA Chief Executive Mark Lyonette said: “The same logic that led all recent Health Secretaries to talk about a ‘pharmacy first’ approach to primary care still applies today. That provides a basis for a serious conversation about investment, even though all parts of government have been asked to look for cost savings.

“We want him to buy into our can-do agenda for urgent care, long-term conditions, medicines optimisation and prevention.”

The Company Chemists Association (CCA)’s spokesperson commented: “Mr Barclay rebegins his role at a crucial time for the pharmacy sector. The Secretary of State will find that community pharmacies are invariably solutions providers and can take positive steps forward to relieve pressures across the sector.

"We are encouraged that the Health Secretary previously worked on a ‘Pharmacy First’ model, however pharmacies need immediate investment for this plan to be realised.

“A real-term cut in funding spanning eight years is having a deeply concerning impact on the sector’s ability to care for patients.”

Citing the data from its recent research, CCA said, “permanent closures are happening at a concerning rate in areas of deprivation, with 41% of permanent closures since 2015 occurring in the 20% most deprived areas of England. It is only with investment that community pharmacy’s full potential can be realised so it can deliver more for patients and ensure the best value for taxpayers.”

During his previous tenure, we successfully concluded negotiations for year 4 and 5 of the CPCF and we were very grateful to him for all his efforts during this process, said the Pharmaceutical Services Negotiating Commitee (PSNC) Chief Executive Janet Morrison.

"He re-joins the Department at a crucial time for community pharmacy as we continue to experience unsustainable and damaging pressures, due to chronic underfunding of the sector.

"We look forward to working with Mr Barclay, the Pharmacy Minister and their colleagues to further dialogue about the future role and funding of community pharmacy.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less